Amoy Diagnostics Co., Ltd. (SHE:300685)
China flag China · Delayed Price · Currency is CNY
18.68
-0.06 (-0.32%)
Aug 11, 2026, 3:04 PM CST

Amoy Diagnostics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,1861,1981,1091,044842.18917.03
Revenue Growth
3.33%8.01%6.27%23.91%-8.16%25.90%
Gross Profit
966.08978.54927.61866.58688.74769.84
Operating Income
397.9385.68277.25269.46143.64235.05
Net Income
355.94361.26254.86261.48263.74239.57
Earnings Per Share
0.890.900.640.660.670.60
EPS Growth
25.48%40.63%-3.03%-1.49%11.67%33.33%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Detection Reagent
951.89876.85859.88611.39699.04
Testing Service
77.3166.5684.94135154.91
Drug Clinical Research Services
158.14160.988.7186.0454.18
Unallocated Other Operations
10.394.649.999.758.91
Total
1,1981,1091,044842.18917.03

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,4321,3421,1811,022753.98718.73
Total Debt
200.49108.657.2656.6853.646.06
Net Cash (Debt)
1,2321,2331,124965.23700.34712.67
Net Cash Growth
2.40%9.77%16.40%37.82%-1.73%6.94%
Net Cash Per Share
3.083.072.822.441.781.78

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
368.86364.82341.85298.72149.04168.16
Capital Expenditures
-72.12-70.23-40.21-44.87-78.29-74.55
Free Cash Flow
296.73294.6301.64253.8570.7593.61
Free Cash Flow Growth
-7.67%-2.33%18.82%258.79%-24.42%-42.50%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
81.46%81.70%83.65%83.05%81.78%83.95%
Operating Margin
33.55%32.20%25.00%25.82%17.06%25.63%
Pretax Margin
34.15%34.31%26.14%28.26%33.97%27.48%
Profit Margin
30.01%30.16%22.98%25.06%31.32%26.13%
FCF Margin
25.02%24.60%27.20%24.33%8.40%10.21%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.4500.4500.3000.1500.1400.128
Dividend Per Share Growth
50.00%50.00%100.00%7.14%9.55%-7.99%
Dividend Yield
2.40%2.25%1.37%0.71%0.56%0.32%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
20.9821.9135.2333.1739.9369.88
Forward PE
19.4623.5226.0732.4848.1466.37
P/FCF Ratio
24.2826.8729.7634.17148.85178.84
PS Ratio
6.086.618.108.3112.5118.26